Monica Margoni
Monica Margoni
PhD student
Verified email at
Cited by
Cited by
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
M Margoni, P Preziosa, M Filippi, MA Rocca
Journal of Neurology 269 (3), 1316-1334, 2022
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: a multicentre, Italian, retrospective, observational study
D Baroncini, M Zaffaroni, L Moiola, L Lorefice, G Fenu, P Iaffaldano, ...
Multiple Sclerosis Journal 25 (3), 399-407, 2019
Ketogenic diet in migraine treatment: a brief but ancient history
F Maggioni, M Margoni, G Zanchin
Cephalalgia 31 (10), 1150-1151, 2011
No evidence of disease activity including cognition (NEDA-3 plus) in naive pediatric multiple sclerosis patients treated with natalizumab
M Margoni, F Rinaldi, A Riccardi, S Franciotta, P Perini, P Gallo
Journal of Neurology 267, 100-105, 2020
Selective cerebellar atrophy associates with depression and fatigue in the early phases of relapse-onset multiple sclerosis
A Lazzarotto, M Margoni, S Franciotta, S Zywicki, A Riccardi, D Poggiali, ...
The Cerebellum 19 (2), 192-200, 2020
Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis
A Favaretto, A Lazzarotto, M Margoni, D Poggiali, P Gallo
Multiple sclerosis and demyelinating disorders 3, 1-10, 2018
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis
A Favaretto, A Lazzarotto, A Riccardi, S Pravato, M Margoni, F Causin, ...
PloS one 12 (10), e0185626, 2017
Early immunotherapy and longer corticosteroid treatment are associated with lower risk of relapsing disease course in pediatric MOGAD
M Nosadini, M Eyre, T Giacomini, M Valeriani, M Della Corte, AD Pratic̣, ...
Neurology: Neuroimmunology & Neuroinflammation 10 (1), e200065, 2022
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex
M Margoni, M Gueye, A Meani, E Pagani, L Moiola, P Preziosa, M Filippi, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (3), 181-188, 2023
Therapy of pediatric-onset multiple sclerosis: state of the art, challenges, and opportunities
M Margoni, F Rinaldi, P Perini, P Gallo
Frontiers in Neurology 12, 676095, 2021
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study
M Margoni, E Pagani, A Meani, L Storelli, S Mesaros, J Drulovic, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (7), 741-752, 2022
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
M Margoni, P Preziosa, MA Rocca, M Filippi
Translational Psychiatry 13 (1), 264, 2023
A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: are we pointing towards a disease spectrum?
S Favaretto, M Margoni, L Salviati, L Pianese, R Manara, C Baracchini
Journal of the Neurological Sciences 396, 108-111, 2019
Monitoring progressive multiple sclerosis with novel imaging techniques
M Petracca, M Margoni, G Bommarito, M Inglese
Neurology and therapy 7, 265-285, 2018
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis
M Margoni, F Rinaldi, S Miante, S Franciotta, P Perini, P Gallo
Multiple Sclerosis Journal–Experimental, Translational and Clinical 5 (3 …, 2019
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
D Landi, F Bovis, A Grimaldi, PO Annovazzi, A Bertolotto, A Bianchi, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (12), 1306-1316, 2022
Retinal hyperreflecting foci associate with cortical pathology in multiple sclerosis
M Pengo, S Miante, S Franciotta, M Ponzano, T Torresin, F Bovis, ...
Neurology: Neuroimmunology & Neuroinflammation 9 (4), e1180, 2022
Axonal water fraction as marker of white matter injury in primary‐progressive multiple sclerosis: A longitudinal study
M Margoni, M Petracca, S Schiavi, M Fabian, A Miller, FD Lublin, ...
European Journal of Neurology 26 (8), 1068-1074, 2019
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis
A Fiore, P Preziosa, N Tedone, M Margoni, C Vizzino, D Mistri, M Gueye, ...
Molecular Psychiatry 28 (4), 1770-1782, 2023
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study
MA Rocca, P Valsasina, A Meani, C Gobbi, C Zecca, F Barkhof, ...
Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 10-18, 2023
The system can't perform the operation now. Try again later.
Articles 1–20